We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+7.43%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$54.5B
AUM Growth
+$2.37B
(+4.5%)
Cap. Flow
-$441M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
28.08%
Holding
980
New
34
Increased
487
Reduced
354
Closed
65
Top Buys
| 1 |
ServiceNow
NOW
|
+$191M |
| 2 |
Amazon
AMZN
|
+$127M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$103M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$77.5M |
| 5 |
NVIDIA
NVDA
|
+$76.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$578M |
| 2 |
Apple
AAPL
|
+$141M |
| 3 |
Kaspi.kz JSC
KSPI
|
+$90.9M |
| 4 |
UnitedHealth
UNH
|
+$76.4M |
| 5 |
Eli Lilly
LLY
|
+$74.5M |
Sector Composition
| 1 | Technology | 29.87% |
| 2 | Healthcare | 15.91% |
| 3 | Financials | 10.7% |
| 4 | Consumer Discretionary | 9.48% |
| 5 | Industrials | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Intellia Therapeutics
NTLA
$1.62B
| – | – |
-243,044
| Closed | -$5.44M |
|
952
OneMain Financial
OMF
$6.96B
| – | – |
-160,000
| Closed | -$7.76M |
|
953
Ovintiv
OVV
$16.2B
| – | – |
-5,175
| Closed | -$243K |
|
954
UiPath
PATH
$6.3B
| – | – |
-61,197
| Closed | -$776K |
|
955
Pacira BioSciences
PCRX
$999M
| – | – |
-609,351
| Closed | -$17.4M |
|
956
Remitly
RELY
$5.1B
| – | – |
-120,011
| Closed | -$1.45M |
|
957
Repligen
RGEN
$8.28B
| – | – |
-5,531
| Closed | -$697K |
|
958
Robert Half
RHI
$4.24B
| – | – |
-20,287
| Closed | -$1.3M |
|
959
Roivant Sciences
ROIV
$24.8B
| – | – |
-1,126,987
| Closed | -$11.9M |
|
960
Reliance Steel & Aluminium
RS
$20.2B
| – | – |
-1,045
| Closed | -$298K |
|
961
Royal Bank of Canada
RY
$299B
| – | – |
-90,000
| Closed | -$9.57M |
|
|
SAGE
962
DELISTED
Sage Therapeutics
SAGE
| – | – |
-64,801
| Closed | -$704K |
|
963
Snap
SNAP
$7.64B
| – | – |
-18,672
| Closed | -$310K |
|
964
Stem
STEM
$56.6M
| – | – |
-866
| Closed | -$19.2K |
|
965
TE Connectivity
TEL
$59B
| – | – |
-121,463
| Closed | -$18.3M |
|
|
TUYA
966
Tuya Inc
TUYA
$1.04B
| – | – |
-10,440
| Closed | -$17.9K |
|
967
Tradeweb Markets
TW
$21.3B
| – | – |
-1,946
| Closed | -$206K |
|
968
Unity
U
$12.7B
| – | – |
-40,511
| Closed | -$659K |
|
969
United Therapeutics
UTHR
$22.8B
| – | – |
-843
| Closed | -$269K |
|
970
Vodafone
VOD
$36.2B
| – | – |
-280,900
| Closed | -$2.49M |
|
971
Voya Financial
VOYA
$9.05B
| – | – |
-19,013
| Closed | -$1.35M |
|
|
CMBT
972
CMB.TECH NV
CMBT
$4.34B
| – | – |
-213,400
| Closed | -$3.53M |
|
|
NBIS
973
Nebius Group N.V.
NBIS
$46.3B
| $0 | ﹤0.01% |
76,441
| – | – |
|
|
ORKA
974
Oruka Therapeutics
ORKA
$5.47B
| – | – |
-2,705
| Closed | -$124K |
|
|
ALTM
975
DELISTED
Arcadium Lithium plc
ALTM
| – | – |
-424,974
| Closed | -$1.43M |
|
Similar funds
Aberdeen Group's Q3 2024 Portfolio in Review
As of Q3 2024, Aberdeen Group held 980 positions worth $54.5B, up 4.5% from $52.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Aberdeen Group's Q3 2024 filing shows 34 new, 487 increased, 354 reduced and 65 closed positions. Its largest new stake was Casey's General Stores: 81,280 shares worth $30.5M. The largest sale was Microsoft, an estimated $578M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q3 2024 buy was Casey's General Stores: 81,280 shares worth $30.5M.
- Aberdeen Group added most to ServiceNow in Q3 2024, an estimated $191M increase.
- Aberdeen Group's biggest Q3 2024 reduction was Microsoft, cutting an estimated $578M.
- Aberdeen Group fully exited Atkore in Q3 2024, selling an estimated $51.9M.
- Aberdeen Group's ten largest holdings make up 28% of its $54.5B portfolio in Q3 2024.
- Aberdeen Group opened 34 new positions and closed 65 in Q3 2024.
- Aberdeen Group's portfolio value rose 4.5% quarter-over-quarter to $54.5B.
Based on Aberdeen Group's 13F filing for Q3 2024, filed 25 Oct 2024.